advertisement

Topcon

11.1 General management, indication (11)

Showing records 1 to 11

Display all abstracts in classification 11.1 General management, indication

Search within classification 11.1 General management, indication
25660 The impact of common classes of topical antiglaucoma medications on central corneal thickness--own observations
Wierzbowska J; Lagocka A; Siemiatkowska A; Robaszkiewicz J; Stankiewicz A; Sierdzinski J
Klinika Oczna 2009; 111: 12 323-326
26170 Glaucoma management during pregnancy
Denis D; Touvron G
Journal Français d'Ophtalmologie 2010; 33: 346-349
25888 Considerations in glaucoma therapy: Fixed combinations versus their component medications
Higginbotham EJ
Clinical Ophthalmology 2010; 4: 1-9
25691 Comparing anatomical pattern of topical anti-glaucoma medications associated lacrimal obstruction with a control group
Kashkouli MB; Pakdel F; Hashemi M; Ghaempanah MJ; Rezaee R; Kaghaz-Kanani R; Ahadian A
Orbit 2010; 29: 65-69
25787 Medical management of glaucoma: An overview
Rathore KS; Nema RK
International Journal of PharmTech Research 2009; 1: 863-869
25954 Medical treatment of primary open-angle glaucoma
Sredkova M; Vassileva P
Autonomic and Autacoid Pharmacology 2010; 30: 49-50
25649 Pharmacological and environmental factors in primary angle-closure glaucoma
Subak-Sharpe I; Low S; Nolan W; Foster PJ
British Medical Bulletin 2010; 93: 125-143
25806 The current treatment of refractory glaucoma
Zhu Q; Hu Z
Chinese Ophthalmic Research 2010; 28: 371-374
25718 Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications
Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC
Cornea 2010; 29: 618-621
25721 Physicians treatment decisions, patient persistence, and interruptions in the continuous use of prostaglandin therapy in glaucoma
Hahn SR; Kotak S; Tan J; Kim E
Current Medical Research and Opinion 2010; 26: 957-963
26227 Consultant clinical decision making in a glaucoma clinic
Murdoch I; Johnston RL
Eye 2010; 24: 1028-1030

Issue 12-2

Change Issue


advertisement

Oculus